{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:47:40Z","timestamp":1783648060179,"version":"3.55.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/rlu.0000000000000935","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T16:37:36Z","timestamp":1439915856000},"page":"845-850","source":"Crossref","is-referenced-by-count":43,"title":["Peptide Receptor Radionuclide Therapy\u2013Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors"],"prefix":"10.1097","volume":"40","author":[{"given":"Brian P.","family":"Riff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Soulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pryma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonita","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursina R.","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210204","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R2-1-20210204","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors.","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"key":"R3-1-20210204","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.surg.2003.07.025","article-title":"Aggressive surgery for metastatic liver neuroendocrine tumors.","volume":"134","author":"Norton","year":"2003","journal-title":"Surgery"},{"key":"R4-1-20210204","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.gassur.2005.08.023","article-title":"Surgery for primary pancreatic neuroendocrine tumors.","volume":"10","author":"Norton","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"R5-1-20210204","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/erc.0.0100451","article-title":"Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.","volume":"10","author":"de Herder","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"R6-1-20210204","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"R7-1-20210204","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group.","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"R8-1-20210204","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors.","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"R9-1-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1510015","article-title":"Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.","volume":"151","author":"Kaltsas","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R10-1-20210204","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.beem.2007.01.007","article-title":"Neuroendocrine tumors. Peptide receptor radionuclide therapy.","volume":"21","author":"Forrer","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R11-1-20210204","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/snuc.2002.31563","article-title":"Receptor-mediated radiotherapy with Y-DOTA-DPhe-tyr-octreotide: the experience of the European Institute of Oncology group.","volume":"32","author":"Chinol","year":"2002","journal-title":"Semin Nucl Med"},{"key":"R12-1-20210204","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s002590100574","article-title":"177Lu-DOTAOTyr3octreotate: comparison with 111In-DTPAooctreotide in patients.","volume":"28","author":"Kwekkeboom","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R13-1-20210204","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bpg.2013.01.004","article-title":"Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.","volume":"26","author":"Bergsma","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R14-1-20210204","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00259-008-0778-1","article-title":"Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.","volume":"35","author":"Bodei","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-1-20210204","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog 177 lu-DOTA 0,Tyr3octreotate: toxicity, efficacy, and survival.","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"key":"R16-1-20210204","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2967\/jnumed.112.119347","article-title":"Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate.","volume":"54","author":"Sabet","year":"2013","journal-title":"J Nucl Med"},{"key":"R17-1-20210204","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bjs.6468","article-title":"Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease.","volume":"96","author":"Frilling","year":"2009","journal-title":"Br J Surg"},{"key":"R18-1-20210204","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2009.22.8585","article-title":"90Y-edotreotide for metastatic carcinoid refractory to octreotide.","volume":"28","author":"Bushnell","year":"2010","journal-title":"J Clin Oncol"},{"key":"R19-1-20210204","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"R20-1-20210204","first-page":"792","article-title":"DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.","volume":"24","author":"Otte","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"R22-1-20210204","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jvir.2007.04.018","article-title":"Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.","volume":"18","author":"Ruutiainen","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"R23-1-20210204","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury.","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-1-20210204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"key":"R25-1-20210204","first-page":"292","article-title":"How valuable is ascitic cytology in the detection and management of malignancy Postgrad Med J.","volume":"79","author":"Karoo","year":"2003","journal-title":""},{"key":"R26-1-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1440-1746.1994.tb01215.x","article-title":"Histopathology of portal tracts in livers after transcatheter arterial chemoembolization therapy for hepatocellular carcinoma.","volume":"9","author":"Kobayashi","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"R27-1-20210204","first-page":"597","article-title":"The human liver after radiation injury. A form of veno-occlusive disease.","volume":"48","author":"Reed","year":"1966","journal-title":"Am J Pathol"},{"key":"R28-1-20210204","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","article-title":"Hepatotoxicity of chemotherapy.","volume":"33","author":"Floyd","year":"2006","journal-title":"Semin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:12:59Z","timestamp":1620972779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201511000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000935","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}